Trading Review for Allion Healthcare Inc. issued by Beacon Equity
The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
(EMAILWIRE.COM, October 22, 2009 ) DALLAS, Texas - BeaconEquity.com announces an investment report featuring healthcare company Allion Healthcare Inc. (Nasdaq: ALLI).
The investment report on Allion Healthcare Inc. (Nasdaq: ALLI) should be of particular interest to other healthcare companies: BioScript Inc. (Nasdaq: BIOS), Express Scripts Inc. (Nasdaq: ESRX) and CVS Caremark Corp. (NYSE: CVS).
It is available at: http://www.beaconequity.com/i/ALLI
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
Allion Healthcare Inc. (ALLI) is a provider of specialty pharmacy and healthcare management services to HIV/AIDS and other chronically ill patients. Under the trade name MOMSPharmacy, the Company markets HIV/AIDS drug therapies as well as nutritional supplies. Through the Company's Biomed America division, intravenous immunoglobulin and other health therapies are provided to patients nationwide.
Message Board Search for ALLI: http://www.boardcentral.com/boards/ALLI
In the report, the analyst notes:
“On October 18, the Company announced that it entered into agreement to be acquired by an affiliate of H.I.G Capital LLC in a transaction worth approximately $278 million, which includes $199 million in cash and the assumption of $78 million of the Company's debt. In a unanimous vote, the board of directors as well as a special committee of independent directors approved management's decision to be acquired.
“Details of the agreement include the receipt of $6.60 per share to ALLI stockholders, a more than 30% premium over the average share price of ALLI over the past five trading days prior to the announcement. The agreement is expected to close during the first quarter of 2010.”
To read the entire report visit: http://www.beaconequity.com/i/ALLI
See what investors are saying about these stocks at: http://www.stockhideout.com/
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
The investment report on Allion Healthcare Inc. (Nasdaq: ALLI) should be of particular interest to other healthcare companies: BioScript Inc. (Nasdaq: BIOS), Express Scripts Inc. (Nasdaq: ESRX) and CVS Caremark Corp. (NYSE: CVS).
It is available at: http://www.beaconequity.com/i/ALLI
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
Allion Healthcare Inc. (ALLI) is a provider of specialty pharmacy and healthcare management services to HIV/AIDS and other chronically ill patients. Under the trade name MOMSPharmacy, the Company markets HIV/AIDS drug therapies as well as nutritional supplies. Through the Company's Biomed America division, intravenous immunoglobulin and other health therapies are provided to patients nationwide.
Message Board Search for ALLI: http://www.boardcentral.com/boards/ALLI
In the report, the analyst notes:
“On October 18, the Company announced that it entered into agreement to be acquired by an affiliate of H.I.G Capital LLC in a transaction worth approximately $278 million, which includes $199 million in cash and the assumption of $78 million of the Company's debt. In a unanimous vote, the board of directors as well as a special committee of independent directors approved management's decision to be acquired.
“Details of the agreement include the receipt of $6.60 per share to ALLI stockholders, a more than 30% premium over the average share price of ALLI over the past five trading days prior to the announcement. The agreement is expected to close during the first quarter of 2010.”
To read the entire report visit: http://www.beaconequity.com/i/ALLI
See what investors are saying about these stocks at: http://www.stockhideout.com/
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Contact Information:
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |